These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 17897281)

  • 1. Complex regional pain syndrome type I after infliximab infusion.
    Kachko L; Efrat R; Ami SB; Katz J; Mukamel M
    Paediatr Anaesth; 2007 Nov; 17(11):1112-4. PubMed ID: 17897281
    [No Abstract]   [Full Text] [Related]  

  • 2. Complex regional pain syndrome after infliximab infusion.
    Chahine LM; Patrick R; Tavee J
    J Pain Symptom Manage; 2008 Sep; 36(3):e2-4. PubMed ID: 18639436
    [No Abstract]   [Full Text] [Related]  

  • 3. Re: Complex regional pain syndrome after infliximab infusion.
    Russo MA; Dorahy DJ
    J Pain Symptom Manage; 2009 Mar; 37(3):e9-10. PubMed ID: 19268811
    [No Abstract]   [Full Text] [Related]  

  • 4. Tolerability of shortened infliximab infusion times in patients with inflammatory bowel diseases: a single-center cohort study.
    Breynaert C; Ferrante M; Fidder H; Van Steen K; Noman M; Ballet V; Vermeire S; Rutgeerts P; Van Assche G
    Am J Gastroenterol; 2011 Apr; 106(4):778-85. PubMed ID: 21407184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accelerated infliximab infusions are safe and well tolerated in patients with inflammatory bowel disease.
    Clare DF; Alexander FC; Mike S; Dan G; Allan F; Lisa W; Peter HJ
    Eur J Gastroenterol Hepatol; 2009 Jan; 21(1):71-5. PubMed ID: 19060632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful intravenous regional block with low-dose tumor necrosis factor-alpha antibody infliximab for treatment of complex regional pain syndrome 1.
    Bernateck M; Rolke R; Birklein F; Treede RD; Fink M; Karst M
    Anesth Analg; 2007 Oct; 105(4):1148-51, table of contents. PubMed ID: 17898403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Posterior reversible encephalopathy syndrome following infliximab infusion.
    Zamvar V; Sugarman ID; Tawfik RF; Macmullen-Price J; Puntis JW
    J Pediatr Gastroenterol Nutr; 2009 Jan; 48(1):102-5. PubMed ID: 19172132
    [No Abstract]   [Full Text] [Related]  

  • 8. Timing infliximab therapy in pediatric Crohn's disease.
    Kirschner BS; Huo D
    Gastroenterology; 2007 Mar; 132(3):1167-70. PubMed ID: 17383435
    [No Abstract]   [Full Text] [Related]  

  • 9. [Efficacy of premedication with intravenous corticosteroids and antihistaminics in preventing infusion reactions to infliximab].
    Bermejo F; López San Román A; Algaba A; van Domselaar M; Carneros JA; Rivero M; Piqueras B; Valer MP
    Gastroenterol Hepatol; 2008 Dec; 31(10):629-32. PubMed ID: 19174078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical challenges and images in GI. Oral lichenoid reaction in a patient with Crohn's disease receiving infliximab.
    Moss AC; Treister NS; Marsee DK; Cheifetz AS
    Gastroenterology; 2007 Feb; 132(2):488, 829. PubMed ID: 17261307
    [No Abstract]   [Full Text] [Related]  

  • 11. Combination therapy with infliximab and immunomodulators: is the glass half empty?
    Deshpande AR; Abreu MT
    Gastroenterology; 2008 Jun; 134(7):2161-3. PubMed ID: 18482585
    [No Abstract]   [Full Text] [Related]  

  • 12. Worsening alopecia areata and de novo occurrence of multiple halo nevi in a patient receiving infliximab.
    Fabre C; Dereure O
    Dermatology; 2008; 216(2):185-6. PubMed ID: 18216487
    [No Abstract]   [Full Text] [Related]  

  • 13. Infliximab: new indication. Ulcerative colitis: caution is needed due to long-term risks.
    Prescrire Int; 2007 Oct; 16(91):194. PubMed ID: 17926832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repeated infliximab therapy after serum sickness-like reaction in Crohn's disease.
    Miheller P; Muzes G; Lakatos G; Mihály E; Tulassay Z
    J Emerg Med; 2007 Feb; 32(2):209-10; author reply 210. PubMed ID: 17307639
    [No Abstract]   [Full Text] [Related]  

  • 15. Infusion reactions and their management.
    Mayer L; Young Y
    Gastroenterol Clin North Am; 2006 Dec; 35(4):857-66. PubMed ID: 17129817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid infliximab infusions in pediatric inflammatory bowel disease.
    Yeckes AR; Hoffenberg EJ
    J Pediatr Gastroenterol Nutr; 2009 Jul; 49(1):151-4. PubMed ID: 19516188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Infliximab-induced pustular psoriasis in a patient with Crohn's disease].
    Monteagudo Sánchez B; Cabanillas M; Ortiz-Marin S; Gallego-Ojea JC
    Gastroenterol Hepatol; 2009 Mar; 32(3):175-6. PubMed ID: 19233516
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug-induced lupus associated with infliximab and adalimumab in an adolescent with Crohn disease.
    Zella GC; Weinblatt ME; Winter HS
    J Pediatr Gastroenterol Nutr; 2009 Sep; 49(3):355-8. PubMed ID: 19516196
    [No Abstract]   [Full Text] [Related]  

  • 19. Cutaneous metastatic Crohn's disease responsive to infliximab.
    Petrolati A; Altavilla N; Cipolla R; Fenderico P; Forlini G; Nasoni S; Rossi Z
    Am J Gastroenterol; 2009 Apr; 104(4):1058. PubMed ID: 19259072
    [No Abstract]   [Full Text] [Related]  

  • 20. Palmoplantar pustulosis and acrodermatitis in a patient treated with infliximab for Crohn's sacroiliitis.
    Wermuth J; Kind F; Steuerwald M
    Clin Gastroenterol Hepatol; 2009 Feb; 7(2):A28. PubMed ID: 19187898
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.